IMRX icon

Immuneering
IMRX

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$17.5
282% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Chardan Capital
Chardan Capital
Geulah Livshits
50% 1-yr IMRX win rate
13 Nov ‘25 2 months ago
Leerink Partners
Leerink Partners
Andrew Berens
0% 1-yr IMRX win rate
31 Oct ‘25 2 months ago